| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |